1. Les Laboratoires Servier (28 from 290 patents)

2. Vernalis &r&d) Ltd. (28 from 68 patents)

3. Les Laboratories Servier (6 from 53 patents)

4. Novartis Ag (2 from 3,923 patents)

5. Hybrigenics (1 from 2 patents)

6. Vernals (r&d) Ltd (1 from 1 patent)

7. Vernalis Limited (2 patents)

1. 11466023 - Combination of a Mcl-1 inhibitor and a standard of care treatment for hematologic cancers, uses and pharmaceutical compositions thereof

2. 11332472 - Substituted piperidines as inhibitors of ubiquitin specific protease 7

3. 11058689 - Pyrrole compounds, a process for their preparation and pharmaceutical

4. 11046681 - Substituted piperidines for the treatment of cancer

5. 11028070 - Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them

6. 10765680 - Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof

7. 10711010 - Hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them

8. 10689364 - Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them

9. 10688101 - Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them

10. 10662173 - Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them

11. 10654849 - (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

12. 10618909 - Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

13. 10457687 - Aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them

14. 10457689 - Ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them

15. 10414754 - Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them